1. Home
  2. MBOT vs MIST Comparison

MBOT vs MIST Comparison

Compare MBOT & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MBOT
  • MIST
  • Stock Information
  • Founded
  • MBOT 2010
  • MIST 2003
  • Country
  • MBOT United States
  • MIST Canada
  • Employees
  • MBOT N/A
  • MIST N/A
  • Industry
  • MBOT Medical/Dental Instruments
  • MIST Biotechnology: Pharmaceutical Preparations
  • Sector
  • MBOT Health Care
  • MIST Health Care
  • Exchange
  • MBOT Nasdaq
  • MIST Nasdaq
  • Market Cap
  • MBOT 94.6M
  • MIST 89.8M
  • IPO Year
  • MBOT N/A
  • MIST N/A
  • Fundamental
  • Price
  • MBOT $2.60
  • MIST $1.60
  • Analyst Decision
  • MBOT Strong Buy
  • MIST Strong Buy
  • Analyst Count
  • MBOT 1
  • MIST 2
  • Target Price
  • MBOT $9.00
  • MIST $7.50
  • AVG Volume (30 Days)
  • MBOT 998.8K
  • MIST 1.8M
  • Earning Date
  • MBOT 08-13-2025
  • MIST 08-07-2025
  • Dividend Yield
  • MBOT N/A
  • MIST N/A
  • EPS Growth
  • MBOT N/A
  • MIST N/A
  • EPS
  • MBOT N/A
  • MIST N/A
  • Revenue
  • MBOT N/A
  • MIST N/A
  • Revenue This Year
  • MBOT N/A
  • MIST N/A
  • Revenue Next Year
  • MBOT N/A
  • MIST N/A
  • P/E Ratio
  • MBOT N/A
  • MIST N/A
  • Revenue Growth
  • MBOT N/A
  • MIST N/A
  • 52 Week Low
  • MBOT $0.82
  • MIST $0.63
  • 52 Week High
  • MBOT $3.38
  • MIST $2.75
  • Technical
  • Relative Strength Index (RSI)
  • MBOT 54.60
  • MIST 83.15
  • Support Level
  • MBOT $2.44
  • MIST $1.86
  • Resistance Level
  • MBOT $2.77
  • MIST $1.97
  • Average True Range (ATR)
  • MBOT 0.13
  • MIST 0.14
  • MACD
  • MBOT 0.01
  • MIST 0.06
  • Stochastic Oscillator
  • MBOT 63.83
  • MIST 100.00

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a clinical-stage medical device company specializing in the research, design and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. It is focused on leveraging its robotic technologies to redefine surgical robotics while improving surgical outcomes for patients. Using its LIBERTY technological platform, the company is developing the first-ever fully disposable robot for various endovascular interventional procedures.

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Share on Social Networks: